VIRVir Biotechnology, Inc.
$10.57+82% 1Y
$10.57
$5.1252 weeks$11.78
Is the price fair?
What VIR's price assumes
Vir Biotechnology, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 26.1× revenue.
26.1
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.34
Price / book · today's price, fiscal year to Dec 31, 2025
- EV / sales
- 19.4
EV / sales
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 2.34
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 19.4
- Market capitalisation169.2 million shares, counted Jul 29, 2026
- $1.79B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.